No Detail Found!

Analysis of the effectiveness of aspirin in preventing preeclampsia in high-risk pregnant women and the influencing factors of preeclampsia

Author(s)
Bingshuang Feng Maternal and Child Health Hospital, Chengdong Avenue, Wujiagang District,Yichang, Hubei Province, China
Sumin Zhang Maternal and Child Health Hospital, Chengdong Avenue, Wujiagang District,Yichang, Hubei Province, China
Abstract
This study explores the effect of aspirin on preeclampsia (PE) and analyzes the influencing factors of PE in high-risk pregnant women. We encompassed 110 high-risk pregnant women receiving prenatal examination at Maternal and Child Health Hospital of Yichang City between January 2022 and December 2023, categorized them into the intervention group(n=58,received aspirin therapy), and the control group(n=52,didn't receive pharmaceutical prophylaxis). Clinical and laboratory parameters were compared between groups, with logistic regression performed.The intervention group demonstrated significantly lower PE incidence (25.00% vs 46.55%, P=0.019, 95% CI:[0.170,0.862]), reduced preterm birth (28.85% vs 60.34%, P<0.001, 95%CI:[0.120,0.592]), and decreased neonatal asphyxia (1.92% vs 17.24%, P=0.008, 95% CI:[0.012,0.763]), longer delivery pregnancy week (P<0.001,95%CI:[-2.100,-0.725]), higher neonatal birth weight(P=0.018,95%CI: [-319.524,-30.332]), and improved 1-minute Apgar scores(P=0.001,95%CI:[1,0]). Coagulation profiles revealed elevated PT(P<0.001, 95%CI:[-3.423,-2.355]) and APTT(P<0.001, 95%CI:[-6.544,4.473]), with reduced D-dimer (P<0.001, 95%CI:[0.776,0.887]) and FIB levels (P<0.001,95%CI:[0.389,1.068]). Logistic regression identified that age =35 years old and BMI=28Kg/m2 were risk factors for PE in high-risk pregnant women(P=0.006,OR=3.701,95% CI:1.445-9.475; P=0.001, OR=4.529, 95% CI:1.818-11.281), aspirin use was a protective factor for PE in high-risk pregnant women (P=0.005, OR=0.260, 95% CI:0.101-0.667). Aspirin demonstrates efficacy in safeguarding against PE in women who are at an increased risk of developing the condition.
Publication Details
Page(s) 25-35
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Aspirin, Preeclampsia, influencing factors, preventive effect, High-risk pregnant women
References
Atawia RT,Bunch KL,Toque HA,Caldwell RB,Caldwell RW .2019 .Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front. Biosci, 24(5) : 890-934.
Braune S,Küpper JH,Jung F .2020 .Effect of prostanoids on human platelet function: An overview. Int. J. Mol. Sci, 21(23) : 9020.
Fonseca FA Cercato C .2019 .Cardiovascular risk and obesity. Diabetol. Metab, 11 : 74.
Choi YJ,Shin S YJ .2021 .Aspirin prophylaxis during pregnancy: A systematic review and meta-analysis. Am. J. Prev. Med, 61(1) : e31-e45.
Feng X,Liu Y,Zhang Y,Zhang Y,Li H,Zheng Q,Li N,Tang J,Xu Z J .2021 .New views on endothelial dysfunction in gestational hypertension and potential therapy targets. Drug Discov. Today, 26(6) : 1420-1436.
Frick AP .2021 .Advanced maternal age and adverse pregnancy outcomes. Best Pract. Res. Clin. Obstet, 70 : 92-100.
Ghesquiere L,Guerby P,Marchant I,Kumar N,Zare M,Foisy MA,Roberge S,Bujold E .2023 .Comparing aspirin 75 to 81mg vs 150 to 162mg for prevention of preterm preeclampsia: Systematic review and metaanalysis. Am. J. Obstet. Gynecol. MFM., 5(7) : 101000.
Glick I,Kadish E,Rottenstreich M .2021 .Management of pregnancy in women of advanced maternal age: Improving outcomes for mother and baby. Int. J Womens Health, 13 : 751-759.
Henderson JT,Vesco KK,Senger CA,Thomas RG,Redmond N RG .2021 .Agency for Healthcare Research. Evidence Synthesis No. 205. AHRQ Publication No. 21-05274-EF-1, : .
Hoffman MK,Goudar SS,Kodkany BS,Metgud M,Somannavar M,Okitawutshu J,Lokangaka A,Tshefu A,Bose CL,Mwapule A,Mwenechanya M,Chomba E,Carlo WA,Chicuy J,Figueroa L,Garces A,Krebs NF,Jessani S,Zehra F,Saleem S,Goldenberg RL,Kurhe K,Das P,Patel A,Hibberd PL,Achieng E,Nyongesa P,Esamai F,Liechty EA,Goco N,Hemingway-Foday J,Moore J,Nolen TL,McClure EM,Koso-Thomas M,Miodovnik M,Silver R,Derman RJ .2020 .Lowdose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): A randomised, double-blind, placebocontrolled trial. Lancet, 395(10220) : 285-293.
Huai J,Lin L,Juan J,Chen J,Li B,Zhu Y,Yu M,Yang H M .2021 .Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension. J. Clin. Hypertens. (Greenwich), 23(5) : 1060-1067.
Huppertz B .2019 .Traditional and new routes of trophoblast invasion and their implications for pregnancy diseases. Int. J. Mol Sci, 21(1) : 289.
Khadivzadeh T,Shojaeian Z,Sahebi A .2023 .High risk-pregnant women's experiences of risk management: A qualitative study. Int. J. Community Based Nurs. Midwifery, 11(1) : 57-66.
Mahajan S Kumar P .2013 .Preimplantation and postimplantation therapy for the treatment of reproductive failure. J. Hum. Reprod. Sci., 6(2) : 88-92.
Lin L,Li G,Zhang W,Wang YL,Yang H .2019 .Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells. J. Cell Physiol, 234(10) : 18928-18941.
Liu YH,Zhang YS,Chen JY,Wang ZJ,Liu YX,Li JQ,Xu XJ,Xie NJ,Lye S,Tan N,Duan CY,Wei YX,He PC .2023 .Comparative effectiveness of prophylactic strategies for preeclampsia: A network meta-analysis of randomized controlled trials. Am. J. Obstet. Gynecol., 228(5) : 535-546.
Ma'ayeh M and Costantine MM .2020 .Prevention of preeclampsia. Semin. Fetal. Neonata.l Med, 25(5) : 101123.
Mirabito Colafella KM,Neuman RI,Visser W,Danser AHJ,Versmissen J .2020 .Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition? Basic Clin. , 127(2) : 132-141.
Ninan K,Ali R,Morfaw F,McDonald SD F .2023 .Prevention of pre-eclampsia with aspirin: A systematic review of guidelines and evaluation of the quality of recommendation evidence. Int. J. Gynaecol. Obstet., 161(1) : 26-39.
Palomo I,Wehinger S,Andrés V,García-García FJ,Fuentes E .2024 .RhoA/rho kinase pathway activation in age-associated endothelial cell dysfunction and thrombosis. J. Cell Mol. Med, 28(8) : e18153.
Paredes C,Hsu RC,Tong A,Johnson JR .2021 .Obesity and pregnancy. Neoreviews, 22(2) : e78-e87.
Poon LC,Shennan A,Hyett JA,Kapur A,Hadar E,Divakar H,McAuliffe F,da Silva F,von Dadelszen P,McIntyre HD,Kihara AB,Di Renzo GC,Romero R,D'Alton M,Berghella V,Nicolaides KH,Hod M .2019 .The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia: A pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet., 145(Suppl 1) : 1-33.
Roberge S,Bujold E,Nicolaides KH .2018 .Metaanalysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage. Am. J. Obstet. Gynecol., 218(5) : 483-489.
Rolnik DL,Nicolaides KH,Poon LC .2022 .Prevention of preeclampsia with aspirin. Am. J. Obstet. Gynecol., 226 : S1108-S1119.
Rolnik DL,Nicolaides KH,Poon LC .2022 .Prevention of preeclampsia with aspirin. Am. J. Obstet. Gynecol., 226 : S1108-S1119.
Rothwell PM,Cook NR,Gaziano JM,Price JF,Belch JFF,Roncaglioni MC,Morimoto T,Mehta Z T .2018 .Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: Analysis of individual patient data from randomised trials. Lancet, 392(10145) : 387-399.
Shi P,Zhao L,Yu S,Zhou J,Li J,Zhang N,Xing B,Cui X,Yang S X .2021 .Differences in epidemiology of patients with preeclampsia between China and the US (Review). Exp Ther Med, 22(3) : 1012.
Stepan H,Galindo A,Hund M,Schlembach D,Sillman J,Surbek D,Vatish M .2023 .Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction. Ultrasound Obstet, 61(2) : 168-180.
Stepan H,Hund M,Andraczek T .2020 .Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome. , 75(4) : 918-926.
Verlohren S,Brennecke SP,Galindo A,Karumanchi SA,Mirkovic LB,Schlembach D,Stepan H,Vatish M,Zeisler H,Rana S H .2022 .Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia. , 27 : 42-50.
Vitner D,Harris K,Maxwell C,Farine D C .2019 .Obesity in pregnancy: A comparison of four national guidelines. J. Matern. Fetal. Neonatal. Med, 32(15) : 2580-2590.
0

Citations

0

Downloads

108

Views